Dishman Pharmaceuticals & Chemicals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 17	Mar ' 16	Mar ' 15	Mar ' 14	Mar ' 13

Sales

451.49

510.39

478.69

473.28

484.64

Operating profit

148.13

170.78

149.25

176.21

167.55

Interest

39.17

68.66

68.13

69.22

51.10

Gross profit

179.76

164.50

148.12

162.97

130.04

EPS (Rs)

1.50

10.80

7.27

10.75

7.83

Other income

70.80

62.38

67.00

55.98

13.59

Stock adjustment

-10.48

8.86

-22.69

-8.49

3.31

Raw material

139.41

179.07

196.23

178.97

173.50

Power and fuel

-

-

31.67

-

-

Employee expenses

66.76

65.89

58.88

58.38

58.21

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

107.67

85.79

65.35

68.21

82.06

Provisions made

-

-

-

-

-

Depreciation

135.85

44.25

44.13

44.13

35.34

Taxation

19.67

33.10

45.35

32.05

31.52

Net profit / loss

24.24

87.15

58.64

86.79

63.18

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.28

16.14

16.14

16.14

16.14

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

311.49

311.11

311.77

Agg.of non promotoholding (%)

-

-

38.60

38.55

38.63

OPM (%)

32.81

33.46

31.18

37.23

34.57

GPM (%)

34.42

28.72

27.14

30.79

26.10

NPM (%)

4.64

15.22

10.75

16.40

12.68